Seems like an out-of-date article for one that was just published. Completely misses the Novartis ALK drug LDK378 that's been in Phase I since the beginning of the year: http://www.clinicaltrials.gov/ct2/show/study/NCT01283516?term=alk&rank=1&show_locs=Y#locn On '113, just re-hashes some of the earlier information that was disclosed a while back. Peter